Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/18
End: 02/14/20
Due: 02/14/21
Phase: N/A
Priority: Normal
Start: 09/25/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/21/24
End: 03/31/25
Due: 03/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Performance Evaluation of T-TAS 01 PL Chip | NCT03621020 | Hikari Dx, Inc. | user2@example.com | None | 2018-09-01 | 2020-02-14 | 2021-02-14 | - | - | 2025-07-14 |
| Clinical Performance Evaluation of T-TAS®01 HD Chip | NCT06087198 | Hikari Dx, Inc. | user2@example.com | None | 2023-09-25 | 2025-06-30 | 2026-06-30 | - | - | 2025-07-14 |
| Clinical Validation of the RENISCHEM L-FABP POC Assay | NCT04864847 | Hikari Dx, Inc. | user2@example.com | None | 2021-10-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| T-TAS® WS Method Comparison | NCT06710262 | Hikari Dx, Inc. | user2@example.com | None | 2024-08-21 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |